Stimulation of the Vascular Endothelium and Angiogenesis by Blood-Flow-Restricted Exercise.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
29 11 2022
Historique:
received: 05 11 2022
revised: 26 11 2022
accepted: 27 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Blood-flow-restricted exercise (BFRE) has been gaining constantly increasing interest in rehabilitation, but its influence on endothelial functions has not been well studied yet. Our aim is to examine the influence of low-resistance BFRE on endothelial functions and angiogenesis. This prospective cross-over study involved 35 young healthy adults. They conducted a 21-min low-resistant exercise with blood flow restricted by pressure cuffs placed on arms and tights. They also did the same training but without blood flow restriction. Endothelial parameters and angiogenesis biomarkers were evaluated before and up to 20 min after exercise. Both types of exercise increased Flow-Mediated Dilatation (FMD) but elevation after BFRE was more significant compared to the controls. The stiffness index decreased only after BFRE, while the reflection index decreased significantly after both types of exercise but was higher after BFRE. Platelet endothelial cell adhesion molecule (PECAM-1) and vascular endothelial growth factor receptor 2 (VEGFR-2) concentrations were increased by both exercise types but elevations were higher after BFRE compared to the controls. Only BFRE elevated the mean serum CD34 protein concentration. Based on these results, we can assume that low-resistance BFR exercise stimulates angiogenesis and improves endothelial functions more significantly compared to the same training performed without blood flow restriction.

Identifiants

pubmed: 36497934
pii: ijerph192315859
doi: 10.3390/ijerph192315859
pmc: PMC9739167
pii:
doi:

Substances chimiques

Vascular Endothelial Growth Factor A 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Circ Res. 2021 Oct;129(8):e146-e165
pubmed: 34474592
Metabolism. 2019 Sep;98:1-15
pubmed: 31199953
Eur J Sport Sci. 2018 Apr;18(3):397-406
pubmed: 29343183
Echocardiography. 2010 Aug;27(7):873-7
pubmed: 20456479
J Appl Physiol (1985). 2005 Jun;98(6):2137-46
pubmed: 15661835
Scand J Med Sci Sports. 2011 Oct;21(5):653-62
pubmed: 21917016
Int J Environ Res Public Health. 2022 Sep 14;19(18):
pubmed: 36141820
J Strength Cond Res. 2020 Mar;34(3):689-698
pubmed: 30063556
Int J Environ Res Public Health. 2022 May 31;19(11):
pubmed: 35682336
Eur J Appl Physiol. 2016 Apr;116(4):749-57
pubmed: 26822582
Vasa. 2017 Jan;46(1):17-22
pubmed: 27871219
Adv Drug Deliv Rev. 2019 Jun;146:97-125
pubmed: 30267742
Front Physiol. 2019 Apr 17;10:447
pubmed: 31057427
Autoimmun Rev. 2010 Oct;9(12):830-4
pubmed: 20678595
Am J Sports Med. 2021 Jun;49(7):1938-1944
pubmed: 33196300
Braz J Med Biol Res. 2016;49(4):e5100
pubmed: 26909789
Curr Hypertens Rep. 2020 Jul 15;22(8):51
pubmed: 32671492
Eur Heart J. 2019 Aug 7;40(30):2534-2547
pubmed: 31211361
Kardiol Pol. 2021;79(7-8):804-812
pubmed: 34002844
J Cardiol. 2014 Aug;64(2):145-51
pubmed: 24438856
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1440-52
pubmed: 26342064
Cardiol J. 2020;27(2):142-151
pubmed: 29611173
Exerc Sport Sci Rev. 2009 Apr;37(2):78-85
pubmed: 19305199
Front Physiol. 2019 Jun 12;10:656
pubmed: 31244668
Int J Cardiol. 2016 Nov 1;222:813-818
pubmed: 27522380
Mol Biol Rep. 2018 Oct;45(5):1099-1109
pubmed: 30030775
Eur J Appl Physiol. 2011 Dec;111(12):2969-75
pubmed: 21445603
Nat Rev Clin Oncol. 2009 Oct;6(10):569-79
pubmed: 19736552
Clin Physiol Funct Imaging. 2018 Apr 4;:
pubmed: 29618165
J Appl Physiol (1985). 2012 Mar;112(6):956-61
pubmed: 22174400
Int J Vasc Med. 2012;2012:543218
pubmed: 23133756
J Athl Train. 2021 Sep 1;56(9):937-944
pubmed: 34530434
J Vasc Bras. 2018 Apr-Jun;17(2):122-127
pubmed: 30377421
Oxid Med Cell Longev. 2020 Sep 26;2020:1496462
pubmed: 33062134
Med Sci Sports Exerc. 2010 Jul;42(7):1296-302
pubmed: 20019641
J Atheroscler Thromb. 2014;21(1):11-6
pubmed: 24257465
Scand J Med Sci Sports. 2016 May;26(5):478-87
pubmed: 26059748
Int J Sports Med. 2020 Oct;41(11):759-765
pubmed: 32492734
Vasc Health Risk Manag. 2005;1(2):119-29
pubmed: 17315398
Sports Med. 2019 Jan;49(1):95-108
pubmed: 30306467
Int J Environ Res Public Health. 2022 Aug 19;19(16):
pubmed: 36012003
Int J Environ Res Public Health. 2022 Mar 04;19(5):
pubmed: 35270686

Auteurs

Mikołaj Maga (M)

Department of Rehabilitation in Internal Diseases, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Krakow, Poland.
Clinical Department of Angiology, University Hospital in Krakow, 30-688 Krakow, Poland.

Martyna Schönborn (M)

Clinical Department of Angiology, University Hospital in Krakow, 30-688 Krakow, Poland.
Department of Angiology, Faculty of Medicine, Jagiellonian University Medical College, 30-688 Krakow, Poland.

Agnieszka Wachsmann-Maga (A)

Clinical Department of Angiology, University Hospital in Krakow, 30-688 Krakow, Poland.
Department of Angiology, Faculty of Medicine, Jagiellonian University Medical College, 30-688 Krakow, Poland.

Agnieszka Śliwka (A)

Department of Rehabilitation in Internal Diseases, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Krakow, Poland.

Jakub Krężel (J)

Clinical Department of Angiology, University Hospital in Krakow, 30-688 Krakow, Poland.

Aleksandra Włodarczyk (A)

Department of Angiology, Faculty of Medicine, Jagiellonian University Medical College, 30-688 Krakow, Poland.

Marta Olszewska (M)

Department of Pediatrics, Institute of Pediatrics, Faculty of Medicine, Jagiellonian University Medical College, 30-663 Krakow, Poland.

Roman Nowobilski (R)

Department of Rehabilitation in Internal Diseases, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH